Physician profile
Jonathan David Harrison
NPI 1053739821
$4,974.36
in general payments reported to CMS, 2019-2025
12 companies · $551 in 2025
The $551 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $439 · 2020: $36.64 · 2021: $218 · 2022: $2,524 · 2023: $12.93 · 2024: $1,194 · 2025: $551.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $972 · Food and Beverage: $785.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $972.03 |
| Food and Beverage | $785.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,227.79 | 2022 | |
| W. L. Gore & Associates, INC. | $1,193.22 | 2022 | |
| Penumbra, INC. | $1,043.13 | 2020-2024 | Indigo System |
| Shockwave Medical, INC | $587.41 | 2024-2025 | Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary |
| Abbott Laboratories | $288.92 | 2019-2021 | |
| Abiomed | $145.05 | 2025 | |
| Inari Medical, INC. | $125.11 | 2020-2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Actelion Pharmaceuticals US, INC. | $115.04 | 2019 | |
| Pfizer INC. | $95.86 | 2019 | |
| Janssen Pharmaceuticals, INC | $94.39 | 2019 | |
| Stryker Corporation | $40.09 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Argon Medical Devices, INC. | $18.35 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Harrison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.